Community referral for presumptive TB in Nigeria: a comparison of four models of active case finding

A. O. Adejumo, B. Azuogu, O. Okorie, O. M. Lawal, O. J. Onazi, M. Gidado, O. J. Daniel, J. C. Okeibunor, E. Klinkenberg, E. M. H. Mitchell

Advocacy & Communications
Step Up for TB report 2024
Engaging private providers to enhance tuberculosis detection and notification: evidence from TB REACH-Supported projects

Md. Toufiq Rahman, William A. Wells, Oriol Ramis, Vishnu V. Kamineni, Mirjam I. Bakker, Sode Matiku, Miranda Brouwer & Jacob Creswell

ITB-Iplus/GDF-MED/2025/1_ITB document Revision 1
Q&A ITB-Iplus/GDF-MED/2025/1
ITB-Iplus/GDF-MED/2025/1_Annex L. TB medicines target prices
ITB-Iplus/GDF-MED/2025/1_Annex K. Form for Requests for Clarifications or Complaints
ITB-Iplus/GDF-MED/2025/1_Annex J. Global Drug Facility artwork development guidelines
ITB-Iplus/GDF-MED/2025/1_Annex I. GMSD address list
ITB-Iplus/GDF-MED/2025/1_Annex H. Indicative non-binding estimated quantities